Literature DB >> 10533466

Gene therapy for cancer.

J Gómez-Navarro1, D T Curiel, J T Douglas.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10533466     DOI： 10.1016/s0959-8049(99)00061-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

Review 1.  New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles.

Authors:  M A Zaimy; N Saffarzadeh; A Mohammadi; H Pourghadamyari; P Izadi; A Sarli; L K Moghaddam; S R Paschepari; H Azizi; S Torkamandi; J Tavakkoly-Bazzaz
Journal:  Cancer Gene Ther       Date:  2017-06-02       Impact factor: 5.987

2.  A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.

Authors:  Yuko Tsuruta; Larisa Pereboeva; Joel N Glasgow; Daniel T Rein; Yosuke Kawakami; Ronald D Alvarez; Rodney P Rocconi; Gene P Siegal; Paul Dent; Paul B Fisher; David T Curiel
Journal:  Clin Cancer Res       Date:  2007-05-01       Impact factor: 12.531

Review 3.  TRAIL gene therapy: from preclinical development to clinical application.

Authors:  Thomas S Griffith; Brittany Stokes; Tamara A Kucaba; James K Earel; Rebecca L VanOosten; Erik L Brincks; Lyse A Norian
Journal:  Curr Gene Ther       Date:  2009-02       Impact factor: 4.391

4.  Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system.

Authors:  Mariam A Stoff-Khalili; Alexander Stoff; Angel A Rivera; Nilam S Banerjee; Maaike Everts; Scott Young; Gene P Siegal; Dirk F Richter; Minghui Wang; Peter Dall; J Michael Mathis; Zeng B Zhu; David T Curiel
Journal:  Breast Cancer Res       Date:  2005-11-16       Impact factor: 6.466
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.